Cite
Ingale J, Tran K, Kong L, et al. Correction for Ingale et al., Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies. J Virol. 2015;89(12):6526doi: 10.1128/JVI.00596-15.
Ingale, J., Tran, K., Kong, L., Dey, B., McKee, K., Schief, W., Kwong, P. D., Mascola, J. R., & Wyatt, R. T. (2015). Correction for Ingale et al., Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies. Journal of virology, 89(12), 6526. https://doi.org/10.1128/JVI.00596-15
Ingale, Jidnyasa, et al. "Correction for Ingale et al., Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies." Journal of virology vol. 89,12 (2015): 6526. doi: https://doi.org/10.1128/JVI.00596-15
Ingale J, Tran K, Kong L, Dey B, McKee K, Schief W, Kwong PD, Mascola JR, Wyatt RT. Correction for Ingale et al., Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies. J Virol. 2015 Jun;89(12):6526. doi: 10.1128/JVI.00596-15. PMID: 25979984; PMCID: PMC4474303.
Copy
Download .nbib